| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9312026 | Urology | 2005 | 5 Pages |
Abstract
The combination of an every-2-week regimen of docetaxel, EMP, and zoledronic acid is an effective, well-tolerated regimen that results in symptomatic improvement in a significant proportion of patients with AIPC.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
E. Efstathiou, G. Bozas, A. Kostakopoulos, E. Kastritis, C. Deliveliotis, N. Antoniou, D. Skarlos, C. Papadimitriou, M.A. Dimopoulos, A. Bamias,